Preview

Malignant tumours

Advanced search
Fullscreen

For citations:


Fedyanin M.Yu., Polyanskaya E.M., Elsnukaeva  H.M., Tryakin A.A., Pokataev I.А., Ignatova  Е.О., Sergeev  U.S., Bulanov A.A., Tjulandin  S.A. Is it necessary to add anti-angiogenic therapy to chemotherapy in patients with metastatic colorectal cancer and BRAF mutation? The systematic review and meta-analysis results. Malignant tumours. 2020;10(2):36-44. (In Russ.) https://doi.org/10.18027/2224-5057-2020-10-2-3



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)